We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Measuring Antibodies in Saliva a Useful and Easy Strategy to Detect SARS-CoV-2 Infections, Finds Study

By LabMedica International staff writers
Posted on 01 Dec 2021
Print article
Image: Measuring Antibodies in Saliva a Useful and Easy Strategy to Detect SARS-CoV-2 Infections, Finds Study (Photo courtesy of Hospital Sant Joan de Déu Barcelona)
Image: Measuring Antibodies in Saliva a Useful and Easy Strategy to Detect SARS-CoV-2 Infections, Finds Study (Photo courtesy of Hospital Sant Joan de Déu Barcelona)

Measuring antibodies in saliva is a useful and easy strategy to detect SARS-CoV-2 infections, according to a new study.

The study, a collaboration between the Barcelona Institute for Global Health (ISGlobal; Barcelona, Spain) and the Hospital Sant Joan de Déu (HSJD; Barcelona, Spain), used saliva instead of blood to measure virus-specific antibodies in over 1,500 children who attended different summer schools in Barcelona in 2020, as well as around 400 adult staff. Two saliva samples per participant were analyzed, one at the beginning and one at the end of the camp stay, and different antibody types (IgG, IgA and IgM) targeting different viral antigens were measured.

The results show that 3.2% of the summer school participants developed antibodies between the first and second sample, which is indicative of new infections. This is six times higher than the infection rate estimated by weekly PCR screening. In addition, the analysis shows that the percentage of new infections was higher in adults (2.94%) than in children (1.3%), which suggests differences in infection and transmission dynamics. Finally, contrary to what has been observed in blood, asymptomatic people had higher levels of anti-Spike antibodies in saliva, suggesting these antibodies play a protective role in respiratory mucosae.

“We previously demonstrated in other Kids Corona studies that saliva is useful for detecting virus by PCR. With this study, we demonstrate that it’s also an effective and much friendlier way to measure antibodies, making it the ideal sample for children, instead of the more invasive nasal swab,” said Iolanda Jordan from HSJD.

“Studies using saliva are much easier to perform and do not require specialized staff for its collection,” added Juan José García, Chief of Pediatrics at HSJD and coordinator of the Kids Corona study, which means this strategy could prove very useful to measure the incidence in school settings and guide decisions on the kind of measures that need to be implemented. Saliva samples are easy to obtain and useful for measuring antibodies to SARS-CoV-2 in children, which could facilitate epidemiological surveillance in school settings.

Related Links:
ISGlobal 
HSJD 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.